Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J MARTENS

Showing results (521-530 of 530) with videos related to

Pageof 53
Sort By:
You have reached the last page of results.This site can display upto 530 results.
Blood Advances|July 30, 2025
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR AnalysisHemalatha G Rangarajan, Prakash Satwani, Megan M Herr, et al.
The New England Journal of Medicine|June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisJavier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Blood Advances|April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
World Journal of Surgery|September 6, 2022
PREvalence Study on Surgical COnditions (PRESSCO) 2020: A Population-Based Cross-Sectional Countrywide Survey on Surgical Conditions in Post-Ebola Outbreak Sierra LeoneJurre van Kesteren, Alex J van Duinen, Foday Marah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2017
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramF Cardoso, J M S Bartlett, L Slaets, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Blood Advances|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTRKitsada Wudhikarn, Megan M Herr, Min Chen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 20, 2025
Quality of life in patients with gallbladder polyps: a multicentre prospective cohort studySander R W J Martens, Mike van Dooren, Jarmila van der Bilt, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplantSteven J Siegel, Susan DeWolf, Joseph Schmalz, et al.
Pageof 53

Showing results (521-530 of 530) with videos related to

Sort By:
Pageof 53
You have reached the last page of results.This site can display upto 530 results.
Blood Advances|July 30, 2025
Real-World Outcomes of Infections Following Tisagenlecleucel in Patients with B-Cell ALL: A CIBMTR AnalysisHemalatha G Rangarajan, Prakash Satwani, Megan M Herr, et al.
The New England Journal of Medicine|June 21, 2023
Post-Transplantation Cyclophosphamide-Based Graft-versus-Host Disease ProphylaxisJavier Bolaños-Meade, Mehdi Hamadani, Juan Wu, et al.
Blood Advances|April 30, 2025
Impact of Post-Transplant Cyclophosphamide-Based GVHD Prophylaxis in Patients 70 years and Older: An Update from BMT CTN 1703Sameem M Abedin, Michael J Martens, Javier Bolaños-Meade, et al.
World Journal of Surgery|September 6, 2022
PREvalence Study on Surgical COnditions (PRESSCO) 2020: A Population-Based Cross-Sectional Countrywide Survey on Surgical Conditions in Post-Ebola Outbreak Sierra LeoneJurre van Kesteren, Alex J van Duinen, Foday Marah, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 3, 2025
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 2, 2017
Characterization of male breast cancer: results of the EORTC 10085/TBCRC/BIG/NABCG International Male Breast Cancer ProgramF Cardoso, J M S Bartlett, L Slaets, et al.
Biorxiv : the Preprint Server for Biology|February 27, 2026
Differential effects of two common GVHD prophylaxis regimens on the gut microbiome: Results from the BMT CTN 1801 studyJakob Wirbel, Wael Saber, Michael J Martens, et al.
Blood Advances|May 28, 2025
Infection after CD19 chimeric antigen receptor T-cell therapy for large B-cell lymphoma: real-world analysis from CIBMTRKitsada Wudhikarn, Megan M Herr, Min Chen, et al.
HPB : the Official Journal of the International Hepato Pancreato Biliary Association|December 20, 2025
Quality of life in patients with gallbladder polyps: a multicentre prospective cohort studySander R W J Martens, Mike van Dooren, Jarmila van der Bilt, et al.
Medrxiv : the Preprint Server for Health Sciences|March 10, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplantSteven J Siegel, Susan DeWolf, Joseph Schmalz, et al.
Pageof 53